Examining the impact of school policies on HPV vaccination rates
Implementation of School-Entry Policies for Human Papillomavirus Vaccination
This study is looking at how a new rule in Puerto Rico that requires kids aged 11-12 to get the HPV vaccine before starting school is working, and it wants to see how this rule is being applied in different places across the U.S., all to help improve vaccination rates for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Comprehensive Cancer Center/ Univ/pr NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project ID | NIH-10533782 on NIH RePORTER |
What this research studies
This research investigates the implementation of a new policy in Puerto Rico that requires HPV vaccination for adolescents aged 11-12 years enrolling in schools. It aims to understand how this policy affects vaccination rates and to analyze geographic differences in HPV vaccine policy implementation across the U.S. The study will utilize various methods, including surveys, immunization registry data, and qualitative interviews, to gather comprehensive insights. By collaborating with local and national partners, the findings will be shared with stakeholders to improve vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 11-12 years in Puerto Rico who are enrolling in school.
Not a fit: Patients outside the age range of 11-12 years or those not residing in Puerto Rico may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased HPV vaccination rates among adolescents, ultimately reducing the incidence of HPV-related cancers.
How similar studies have performed: Previous research has shown that school-entry vaccination policies can effectively increase vaccination rates, suggesting a positive outlook for this approach.
Where this research is happening
San Juan, United States
- Comprehensive Cancer Center/ Univ/pr — San Juan, United States (Active)
Researchers
- Principal investigator: Colon, Vivian — Comprehensive Cancer Center/ Univ/pr
- Study coordinator: Colon, Vivian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.